PMID- 31738487
OWN - NLM
STAT- MEDLINE
DCOM- 20200521
LR  - 20200521
IS  - 2463-0225 (Electronic)
IS  - 0034-7434 (Linking)
VI  - 70
IP  - 3
DP  - 2019 Sep
TI  - [SAFETY OF THE TREATMENT FOR VOLUNTARY PREGNANCY TERMINATION BY GESTATIONAL AGE. 
      MEDELLIN, COLOMBIA, 2013-2014].
PG  - 174-180
LID - 10.18597/rcog.3267 [doi]
AB  - OBJECTIVE: To describe the safety of medical and surgical treatments used in 
      women seeking voluntary pregnancy termination. METHODS: Historical cohort of all 
      pregnant women with up to 26 weeks of gestation who received treatment for 
      voluntary pregnancy termination in a referral institution in Medellin, Colombia, 
      between January 2013 and December 2014.Sampling was consecutive. Measured 
      variables included sociodemographic and obstetric variables, undesired effects, 
      and complications of the voluntary pregnancy termination treatment. A descriptive 
      analysis was carried out. RESULTS: Overall, 87 women were included. The mean age 
      at the time of termination was 24 years (inter-quartile range [IQR] = 12), 69.0% 
      were single, and 73,4% were unemployed. The main reason for termination was the 
      risk to the mother's health in 61,0% of cases, followed by a history of sexual 
      violence in 26.4% and fetal malformations in 12.6%; a total of 70 women (80,4%) 
      had less than 18 weeks of gestation and were treated with misoprostol plus manual 
      vacuum aspiration; 17 (19,6%) had between 18 and 26 weeks of gestation and were 
      treated with misoprostol followed by dilation and curettage. The first group 
      (gestational age <18 weeks) experienced undesired effects such as pain and 
      vomiting; in the second group (> or equal to 18 weeks), 41.0% of the women 
      experienced hemorrhage. CONCLUSIONS: The risk to the mother's health was the main 
      reason for the termination of pregnancy. Termination before 18 weeks was found to 
      be safe, while termination between 18 and 26 weeks using misoprostol and 
      curettage was associated with a high frequency of hemorrhage.
CI  - Copyright(c) 2019 This is an open-access article distributed under the terms of the 
      Creative Commons Attribution License by-nc-nd/4.0.
FAU - Restrepo-Bernal, Diana Patricia
AU  - Restrepo-Bernal DP
AD  - Universidad CES, Medellin (Colombia).
FAU - Colonia-Toro, Alejandro
AU  - Colonia-Toro A
AD  - Universidad CES-Hospital General de Medellin, Medellin (Colombia).
FAU - Duque-Giraldo, Marle Isabel
AU  - Duque-Giraldo MI
AD  - Psiquiatra de Enlace; MSc en Epidemiologia. Medellin (Colombia).
FAU - Hoyos-Zuluaga, Catalina
AU  - Hoyos-Zuluaga C
AD  - Servicios de consulta y hospitalizacion, Clinica CES, Medellin (Colombia).
FAU - Cruz-Osorio, Vanessa
AU  - Cruz-Osorio V
AD  - Consulta y hospitalizacion Clinica Vida, Medellin (Colombia.
LA  - spa
PT  - Journal Article
PL  - Colombia
TA  - Rev Colomb Obstet Ginecol
JT  - Revista colombiana de obstetricia y ginecologia
JID - 0404263
RN  - 0 (Abortifacient Agents, Nonsteroidal)
RN  - 0E43V0BB57 (Misoprostol)
SB  - IM
MH  - Abortifacient Agents, Nonsteroidal/*administration & dosage
MH  - Abortion, Induced/adverse effects/*methods
MH  - Adolescent
MH  - Adult
MH  - Cohort Studies
MH  - Colombia
MH  - Dilatation and Curettage/methods
MH  - Female
MH  - *Gestational Age
MH  - Humans
MH  - Misoprostol/*administration & dosage
MH  - Pregnancy
MH  - Pregnancy Trimester, Second
MH  - Vacuum Curettage/methods
MH  - Young Adult
OTO - NOTNLM
OT  - salud mental
OT  - Therapeutic abortion
OT  - aborto terapeutico
OT  - abuso sexual
OT  - anomalias congenitas
OT  - congenital abnormalities
OT  - embarazo de alto riesgo
OT  - high risk pregnancy
OT  - mental health
OT  - sexual abuse
COIS- None declared
EDAT- 2019/11/19 06:00
MHDA- 2020/05/22 06:00
CRDT- 2019/11/19 06:00
PHST- 2018/12/13 00:00 [received]
PHST- 2019/09/15 00:00 [accepted]
PHST- 2019/11/19 06:00 [entrez]
PHST- 2019/11/19 06:00 [pubmed]
PHST- 2020/05/22 06:00 [medline]
AID - 10.18597/rcog.3267 [doi]
PST - ppublish
SO  - Rev Colomb Obstet Ginecol. 2019 Sep;70(3):174-180. doi: 10.18597/rcog.3267.